With more people using drugs like Ozempic and Wegovy for weight loss, food companies are paying close attention and trying to adapt to changing eating habits.
People taking tirzepatide injections lost more weight and were more likely to reach specific weight loss targets than those taking semaglutide, according to a new study.
People are also reading… Average weight loss was also consistently higher among those taking tirzepatide over time. After three months, people taking tirzepatide had lost about 5% of their body weight, on average, compared to an average 3% loss among those taking semaglutide. At six months, average weight loss was 8% on tirzepatide and 5% on semaglutide.
Health-care Use of Wegovy and other weight-loss drugs soars among kids and young adults The FDA approved higher doses of both tirzepatide and semaglutide to treat weight loss, but the new study only looked at the doses to treat type 2 diabetes. When the findings from this study were first released in a preprint last year, Novo Nordisk told CNN that it wasn’t a fair comparison.
Wire Cnn Lee-National Tirzepatide Semaglutide Medical Specialties Medicine Health Clinical Medicine Drugs Health Care Pharmacology Medical Treatments Chemicals In Medicine
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Mounjaro leads to significantly more weight loss than Ozempic, study suggestsPeople taking tirzepatide injections lost more weight and were more likely to reach specific weight loss targets than those taking semaglutide, according to a new study.
Read more »
Ozempic vs. Mounjaro: New study reveals which is better to combat obesityBeyond Traditional Diet Pills: Groundbreaking New Weight Loss Drug Is More Effective Than Current Treatments
Read more »
Study finds Mounjaro 'significantly more' effective than Ozempic for weight lossOverweight and obese adults using popular diabetes medications to suppress their appetites are 'significantly more likely' to shed pounds with Eli Lilly's Mounjaro than with Novo Nordisk's Ozempic, a new study has found, a result that could have major implications for one of the hottest new markets in the pharmaceutical field.
Read more »
Mounjaro bests Ozempic for weight loss in first head-to-head comparison of real-world useIn the first head-to-head comparison of two blockbuster drugs, patients taking Mounjaro lost more weight than those taking Ozempic.
Read more »
Ozempic, Mounjaro users turning to protein shakes to help beef up musclesOzempic and Mounjaro users are increasingly turning to protein drinks as a convenient way to supplement protein consumption and combat excess muscle loss.
Read more »
Senate panel to weigh Novo Nordisk subpoena on Ozempic, Wegovy pricesThe U.S. Senate health panel said on Tuesday it would vote this month on whether to subpoena Novo Nordisk to answer questions about U.S. prices for weight loss drugs Ozempic and Wegovy, which are far higher than those in other countries.
Read more »